News
-
MHRA Imigran recall
Thursday | Oct 31 2013The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has alerted pharmacies, dispensing clinics and wholesalers.
-
EMA involves patients
Thursday | Oct 31 2013The European Medicines Agency is exploring ways to increasingly involve patients in the benefit-risk assessment of.
-
$20m for Pharmaxis
Thursday | Oct 31 2013Australian pharmaceutical developer Pharmaxis has elected to take a further $20 million under a financing agreement.
-
NPS weighs in on statins
Thursday | Oct 31 2013NPS MedicineWise has joined the debate sparked by the ABC Catalyst program (PD yesterday) which has.
-
Smith at ASMI event
Thursday | Oct 31 2013The upcoming Australian Self Medication Industry conference will feature pharmacist and naturopath Michael Smith, exploring the.
-
Actelion attractive
Thursday | Oct 31 2013The FDA approval of Actelion’s new pulmonary arterial hypertension therapy Opsumit (PD 22 Oct), has reportedly.
-
$20m threshold locked in
Thursday | Oct 31 2013Federal health minister Peter Dutton has announced that the government will “fast-track approvals of medicines that.
-
Daily aspirin debate
Thursday | Oct 31 2013In a recent study published in Health Technology Assessment, the risks and benefits of daily aspirin.
-
Aspen pricing drop
Thursday | Oct 31 2013Aspen Australia has announced price drops for selected products one month ahead of accelerated price-disclosure effective.
-
APPFSC clarification
Thursday | Oct 31 2013The Advanced Pharmacy Practice Framework Steering Committee (PD yesterday) is a profession wide collaboration, with the.